Mason Street Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Mason Street Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-27,997	Closed	-$3.14M	–	1518
2014 Q4	$3.14M	Sell	27,997 -25,713	-48%	-$2.3M	0.02%	741
2014 Q3	$3.29M	Hold	53,710	–	–	0.03%	699
2014 Q2	$2.46M	Hold	53,710	–	–	0.02%	855
2014 Q1	$2.1M	Sell	53,710 -11,380	-17%	-$381K	0.02%	930
2013 Q4	$1.56M	Buy	65,090 +12,070	+23%	+$275K	0.01%	1041
2013 Q3	$1.48M	Buy	+53,020	New	+$1.46M	0.02%	830

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CGT

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mason Street Advisors's AGIO Position: Q1 2015 in Review

Mason Street Advisors sold out of Agios Pharmaceuticals (AGIO) in Q1 2015, closing a stake of 27,997 shares — an estimated $3.14M sold.

Mason Street Advisors first reported a position in AGIO in Q3 2013 and held it in 6 quarters. The position peaked at $3.29M in Q3 2014. 152 funds tracked by Wall St. Rank hold AGIO as of Q1 2015.

Mason Street Advisors reported no remaining Agios Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 27,997 Agios Pharmaceuticals shares in Q1 2015, an estimated $3.14M.
Mason Street Advisors first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 6 quarters.
Mason Street Advisors's Agios Pharmaceuticals position peaked at $3.29M in Q3 2014.
152 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.